Skip to Main Content

Immediate Pause in the Administration of the Johnson and Johnson COVID-19 vaccine

The FDA is recommending an immediate pause in the administration of the Johnson and Johnson (Janssen) COVID-19 vaccine due reports of six cases of a rare and serious clot (cerebral venous sinus thrombosis)…there has been one associated death…for context, 6.8 million doses of the Johnson and Johnson COVID-19 vaccine have been administered…a link to the FDA statement is below.

Consequently, all CommonSpirit Health facilities should immediately halt administration of the Johnson and Johnson COVID-19 vaccine…there will be an emergency session of the Advisory Committee on Immunization Practices (ACIP) tomorrow (Wednesday, April 14) to review the data…additional guidance might be forthcoming after ACIP meets.

Please be sure all of your sites are aware of this development…our pharmacy and patient safety teams are working to provide additional information today.

Read the full story at the FDA Website.

Publish date: 

Wednesday, April 14, 2021

News

CommonSpirit Health Announces Plans to Expand In-House GPO

APR 04, 2024

CommonSpirit Health, one of the nation's largest nonprofit health systems, is excited to announce its plans to grow its internal Group Purchasing Organization (GPO) – Edgewise. Edgewise is CommonSpirit Health’s in-house GPO.

Read More Additional information about CommonSpirit Health Announces Plans to Expand In-House GPO

CommonSpirit Health Announces Launch of Internal AI Assistant, Insightli

MAR 14, 2024

Designed to streamline workflows and create highly customized assets in an instant, Insightli empowers CommonSpirit to create unique resources and solutions without sharing private information outside of the system.

Read More Additional information about CommonSpirit Health Announces Launch of Internal AI Assistant, Insightli

CommonSpirit's latest bond ratings

MAR 01, 2024

After members of CommonSpirit Health's Executive Leadership and Finance teams met in Chicago this past fall with representatives of the three major bond rating agencies to present and discuss a financial review.

Read More Additional information about CommonSpirit's latest bond ratings